301 related articles for article (PubMed ID: 25137428)
21. Treatment of delayed male puberty: efficacy of aromatase inhibition.
Dunkel L; Wickman S
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1541-6. PubMed ID: 11837512
[TBL] [Abstract][Full Text] [Related]
22. Novel treatment of delayed male puberty with aromatase inhibitors.
Dunkel L; Wickman S
Horm Res; 2002; 57 Suppl 2():44-52. PubMed ID: 12065927
[TBL] [Abstract][Full Text] [Related]
23. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
24. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
Wickman S; Kajantie E; Dunkel L
J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia.
Mauras N; Bishop K; Merinbaum D; Emeribe U; Agbo F; Lowe E
J Clin Endocrinol Metab; 2009 Aug; 94(8):2975-8. PubMed ID: 19470631
[TBL] [Abstract][Full Text] [Related]
26. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
Yanovski JA; Rose SR; Municchi G; Pescovitz OH; Hill SC; Cassorla FG; Cutler GB
N Engl J Med; 2003 Mar; 348(10):908-17. PubMed ID: 12621135
[TBL] [Abstract][Full Text] [Related]
27. Letrozole as a booster therapy in growth hormone deficiency.
Kumar KV; Jayaraman M; Verma A; Modi KD
Indian Pediatr; 2009 Jul; 46(7):625-7. PubMed ID: 19638662
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of P450 aromatase enhances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E.
Wickman S; Dunkel L
J Clin Endocrinol Metab; 2001 Oct; 86(10):4887-94. PubMed ID: 11600558
[TBL] [Abstract][Full Text] [Related]
29. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty.
Hero M; Toiviainen-Salo S; Wickman S; Mäkitie O; Dunkel L
J Bone Miner Res; 2010 Jul; 25(7):1536-43. PubMed ID: 20200972
[TBL] [Abstract][Full Text] [Related]
30. An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys.
Mauras N; Welch S; Rini A; Klein KO
J Pediatr Endocrinol Metab; 2004 Dec; 17(12):1597-606. PubMed ID: 15645693
[TBL] [Abstract][Full Text] [Related]
31. Strategies for maximizing growth in puberty in children with short stature.
Mauras N
Endocrinol Metab Clin North Am; 2009 Sep; 38(3):613-24. PubMed ID: 19717007
[TBL] [Abstract][Full Text] [Related]
32. Use of aromatase inhibitors in children and adolescents: what's new?
Diaz-Thomas A; Shulman D
Curr Opin Pediatr; 2010 Aug; 22(4):501-7. PubMed ID: 20489637
[TBL] [Abstract][Full Text] [Related]
33. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
[TBL] [Abstract][Full Text] [Related]
34. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
[TBL] [Abstract][Full Text] [Related]
35. Cognitive effects of aromatase inhibitor therapy in peripubertal boys.
Hero M; Maury S; Luotoniemi E; Service E; Dunkel L
Eur J Endocrinol; 2010 Jul; 163(1):149-55. PubMed ID: 20421333
[TBL] [Abstract][Full Text] [Related]
36. The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor.
Wickman S; Saukkonen T; Dunkel L
Eur J Endocrinol; 2002 Mar; 146(3):339-46. PubMed ID: 11888840
[TBL] [Abstract][Full Text] [Related]
37. Aromatase inhibitors: a useful additional therapeutic option for slowing down advanced bone age in boys with growth hormone deficiency.
Akın Kağızmanlı G; Özalp Kızılay D; Besci Ö; Yüksek Acinikli K; Özen S; Demir K; Gökşen Şimşek RD; Böber E; Darcan Ş; Abacı A
J Endocrinol Invest; 2024 May; 47(5):1227-1235. PubMed ID: 38040920
[TBL] [Abstract][Full Text] [Related]
38. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
39. Delayed closure of epiphyseal cartilages induced by the aromatase inhibitor anastrozole. Would it help short children grow up?
Faglia G; Arosio M; Porretti S
J Endocrinol Invest; 2000 Dec; 23(11):721-3. PubMed ID: 11194703
[TBL] [Abstract][Full Text] [Related]
40. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.
Lenz AM; Shulman D; Eugster EA; Rahhal S; Fuqua JS; Pescovitz OH; Lewis KA
Pediatrics; 2010 Sep; 126(3):e728-33. PubMed ID: 20713483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
